Angiogenesis inhibitors
US6265403A · kind A · utility
31Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2000 |
| Grant date | Jul 24, 2001 |
| Priority date | — |
| Expiry date | Jan 7, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds which inhibit tyrosine kinase enzymes, compositions which contain tyrosine kinase inhibiting compounds and methods of using tyrosine kinase inhibitors to treat tyrosine kinase-dependent diseases and conditions such as angiogenenesis, cancer, atherosclerosis, diabetic retinopathy, and the like in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.